GEO · The GEO Group, Inc.

Current Thesis

The leg on offer is contract conversion: federal immigration-detention capacity that existed as idle real estate is being turned into signed, five-year, per-facility revenue, and the 2026-08-06 print was the first quarter where that showed up in guidance rather than commentary. Q2 2026 revenue of $732.1M (+15% YoY) beat the $721.4M consensus, adjusted EPS of $0.37 beat $0.29, net income of $47.5M rose 63% and adjusted EBITDA of $142.0M rose 20%. Management lifted the FY2026 GAAP EPS range to $1.27–$1.32 from $1.15–$1.25 against a $1.21 consensus.

The narrative is maturing — the immigration-enforcement buildout has been the dominant driver of this name through 2026's contract announcements, it is well understood by anyone who reads the 8-Ks, and the flow behind it has moderated since the 2026-08-06 print, with the shares holding 3.1% below the $32.77 52-week high on an RSI(14) of 54.3 as of the 2026-09-04 close of $31.77. That is a consolidation reading. The question the tape is asking is whether the range resolves up through $32.77 or back through the high-$20s.

Bullish and bearish views on The GEO Group, Inc.

The model's bull view on The GEO Group, Inc. (GEO), in brief: Q2 2026 beat on both lines (2026-08-06): revenue $732.1M vs $721.428M consensus; adjusted EPS $0.37 vs $0.29 consensus. The bear view: The Q4 guide is the flaw in a raised year (2026-08-06): GAAP EPS $0.28–$0.31 against a $0.35 consensus, and revenue $758–808M against $793.365M. Both cases follow in full.

Bull Case

• Q2 2026 beat on both lines (2026-08-06): revenue $732.1M vs $721.428M consensus; adjusted EPS $0.37 vs $0.29 consensus. Net income $47.5M, +63% YoY; adjusted EBITDA $142.0M, +20% YoY.
• Guidance raised, not merely maintained (2026-08-06): FY2026 GAAP EPS to $1.27–$1.32 from $1.15–$1.25, versus $1.21 consensus. FY2026 net income $168–175M, adjusted EBITDA $550–560M.
• Two named activations inside eight weeks: a five-year ICE support-services contract for the company-owned 1,188-bed Big Horn Facility in Hudson, Colorado, effective 2026-07-09, expected to produce roughly $85M of annual revenue in its first full year of operations; and a five-year ICE support-services contract for the company-owned 1,320-bed Rivers Facility in Winton, North Carolina, effective 2026-08-01, expected to produce roughly $80M of annual revenue in its first full year (announced 2026-07-28).
• Q3 guidance issued above the street (2026-08-06): GAAP EPS $0.35–$0.37 vs $0.32 consensus; revenue $755–805M vs $764.420M consensus. Q3 is the first quarter carrying both new activations.
• The company is a buyer of its own stock: 1.6M shares repurchased for $36.6M in Q2 2026, 10.1M shares for $177M cumulatively, with $323M of authorization remaining as of the 2026-08-06 disclosure.
• Sell-side movement is in the same direction: Jones Trading maintained Buy and raised its target to $40 on 2026-08-06.

Bear Case

• The Q4 guide is the flaw in a raised year (2026-08-06): GAAP EPS $0.28–$0.31 against a $0.35 consensus, and revenue $758–808M against $793.365M. The company guided its December quarter below the street on the same morning it raised the full year.
• The revenue range was narrowed by cutting the top, not lifting the floor: FY2026 revenue went to $2.950–3.050B from $2.950–3.100B, with consensus at $2.984B. The upside case for the year got smaller, even as the EPS case got better.
• Customer concentration is close to absolute. The growth is one federal agency's activation schedule. There is no second buyer for a 1,320-bed detention facility at those economics if ICE changes course.
• No dividend since April 2021, when the board suspended it to maximise debt repayment alongside the move from REIT to taxable C-corporation status. Total return depends entirely on the buyback, deleveraging, and multiple.
• Capex is funding the ramp: FY2026 capital expenditure guided to $135–145M, so a portion of the incremental contract revenue is being spent to activate the beds that produce it.

Setup & Price Structure

Last completed daily close $31.77 (2026-09-04), 3.1% under the $32.77 52-week high, with a three-month price change of +19.1% and RSI(14) at 54.3. Price sitting within 3% of a 52-week high while the 14-day RSI reads mid-range is the signature of a range absorbing supply, not of a stock extending. The $32.77 high is the level that defines it: a weekly close above $32.77 confirms the range resolving higher and puts Jones Trading's $40 target in the frame. Failure of the range is the mirror image, and $28 is where the post-print structure would be gone.

On positioning, the observables are mixed and worth stating separately from any verdict on them. The company itself is bidding — $36.6M of repurchases in the June quarter and $323M of authorisation left — which is a supportive but non-market bid. Coverage is thin and institutional rather than retail: one named, dated target move on 2026-08-06, and published aggregator consensus targets that disagree with each other by a wide margin. No dated insider transaction is in hand for this note. There is no earnings date inside the next 30 days, so the compression that usually accompanies a print is absent here.

Catalyst Calendar (next 30 days)

• 2026-09-30 — US federal fiscal year 2026 ends; FY2027 appropriations or a continuing resolution. Sector-level, not company-dated: multi-year detention funding is more insulated than discretionary lines, but a funding lapse is the kind of headline that moves this pair regardless of contract mechanics.
• No company-dated event is scheduled inside the window. Q3 2026 results are estimated at ~2026-11-05 based on prior-year reporting cadence; no confirmed date was published as of 2026-09-05.

Elapsed catalysts

• Unscheduled, any date — facility activation announcements arrive by press release and 8-K, not on an earnings cadence. The last two carried effective dates of 2026-07-09 and 2026-08-01. (passed 36d ago)

What Would Change Our Mind

The mechanism, not the price, breaks first. The read rests on an activation cadence that produced two named contracts in eight weeks; a stretch from 2026-09-05 through the Q3 print with no new ICE facility contract announced would remove the model, and the story would be left owning a guided-down December quarter. Second, if the Q3 print lands at or below the $0.35 low end of guidance, or reaffirms Q4 at $0.28–$0.31 rather than revising it, the pattern of raising the year while cutting the last quarter becomes the trend rather than an artefact of conservatism. Third, a court order or state action halting operations at Big Horn or Rivers would take out named revenue with a dollar figure already attached to it.

On the tape, a weekly close below $28 ends the leg — that is well beneath the range the shares have held around the 2026-09-04 close of $31.77 and would mark the post-print structure as failed. In the other direction, the theme turning saturated — mainstream coverage of the detention buildout arriving without the bid widening, so that $32.77 caps repeatedly — would say the same thing more slowly.

Correlation Notes

This is a single-name setup, not a group trade; the read does not rest on a sector rotation. The one close comparable is CoreCivic (CXW), and the two respond to the same federal detention headlines with high correlation — a policy shock hits both, which means the pair provides no diversification against the central risk here.

The dominant non-market correlation is political. The US midterm elections on 2026-11-03 fall within days of the estimated Q3 print, so the November window stacks an operating catalyst on top of a policy-sentiment catalyst. Immigration enforcement policy is the input to this business model; a change in the composition of Congress does not change a five-year signed contract, but it changes what the market pays for the next one.

Balance-sheet sensitivity to rates is real but not quantified in this note — the current net debt figure is not in hand, and the 2021 dividend suspension was explicitly framed around debt repayment, so refinancing terms remain a live variable in the equity case.